password
username
Sponsored by CakeMail, an email marketing software.
Newsletter preview

Can't read the email below? Click Here
   
Today on Outsourcing-Pharma.com
 
>  AAIPharma shows first signs of life after bankruptcy
 
>  European countries hailed as top locations for business
 
>  Inyx buys Pharmapac to enrich its offerings
 
>  Wockhardt to build manufacturing hub in India
 
>  Discovery Labs looks to FDA to end manufacturing ordeal
 
 
   
Other top industry news
 
>  Eurand to co-develop GSK drug
 
>  FDA says drug safety reforms
 
>  Report: FDA needs overhaul in drug safety process
 
>  PainCeptor Pharma adds patents to pain portfolio
 
 
 

Pharmaceutical Contract Services
Outsourcing Pharma

Search Forward to a colleague
Tuesday 10 October 2006

Sponsored by SF-Chem
High-quality intermediates
SF-Chem is a supplier of high-quality intermediates to customers in the global chemical industry, particularly pharmaceuticals. The company is highly specialised in chlorine and sulfur chemistry. Click Here

Access full stories



AAIPharma shows first signs of life after bankruptcy
AAIPharma is showing the first signs of life after bankruptcy, buying its first company after emerging from the ordeal - a French-based clinical research organisation (CRO)... Read


European countries hailed as top locations for business
Switzerland, Finland and Sweden are the world's most competitive business locations according to this year's assessment of the best places to do business by the Switzerland-based World Economic Forum (WEF)... Read


Inyx buys Pharmapac to enrich its offerings
In a deal worth up to $19.9m, US drug delivery company Inyx has acquired contract pharmaceutical packaging firm Pharmapac, seeking to enhance its secondary-packaging capabilities for a wide range of dosage forms... Read


Wockhardt to build manufacturing hub in India
Wockhardt has signed a deal with Maharashtra Industrial Development Corporation (MIDC) to establish a special economic zone (SEZ) in Aurangabad, India, in order to expand its manufacturing capabilities... Read


Discovery Labs looks to FDA to end manufacturing ordeal
Following numerous manufacturing failures, Discovery Laboratories believes it has resolved the stability issues that have plagued Surfaxin, its experimental respiratory treatment for infants... Read


All News Headlines for:
October | September | August

Sponsored by Cardinal Health
Cardinal Health enhances drug delivery
Cardinal Health is a world leader in patented drug-delivery technologies. We develop and manufacture advanced drug-delivery systems and partner with nearly every major global pharmaceutical company. Click Here

Previous Headlines

> Data warehouse identified as k ...
> Cardinal attracts Wyeth as cel ...
> Agilent chooses Distek to reac ...
> Tech Group seeks bigger facili ...
> GTC and LFB collaborate on tra ...
> UK pharma faces recruitment is ...
> New clinical research firm ope ...
> Mobious prototype test detects ...
> EU Commission accused of anti- ...
> Tepnel launches new disinfecta ...
Product Categories

> Product & Supplier News - Contract Manufacturing
Related Web Sites

> In-PharmaTechnologist.com
> DrugResearcher.com
> BioPharmaReporter.com
> All our Websites
Other top industry news



Eurand to co-develop GSK drug
Eurand has signed a $42m (€33m) licensing deal with GlaxoSmithKline to make a new formulation of one of the British pharma giant's drugs... Read


FDA says drug safety reforms
The FDA has admitted that more needs to be done to ensure the safe and effective use of prescription drugs, after a report urged the regulator to revamp its drug safety system... Read


Report: FDA needs overhaul in drug safety process
The FDA has come under scrutiny after a report urged the regulator to implement large reforms to ensure the safety of new prescription drugs... Read


PainCeptor Pharma adds patents to pain portfolio
PainCeptor Pharma has announced it has been awarded a series of patents for its drug development programs that focus on pain management... Read



Events - Publisher's Choice

STAY up-to-date with pharmaceutical Innovations
Visit our regularly updated events calendar and learn about important events within the industry today ... Read

ELNS & Laboratory Informatics
4 days of interactive sessions and case studies providing the most current assessment of the future of electronic data recording implementation, integ ... Read



Sponsored by ScinoPharm Taiwan®
Experts in small molecule custom synthesis
ScinoPharm Taiwan®, Ltd. is a process research, development, and manufacturing service provider of active pharmaceutical ingredients (APIs) to the global pharmaceutical industry. Our expertise is in small molecule custom synthesis. Click Here

Forward to a colleague

Subscribe to other Decision News Media e-newsletters - Pharmaceuticals
Breaking news
Pharmaceutical Technology
Drug Discovery
Outsourcing Pharma
Biopharmaceutical Science and Business
Laboratory Equipment
Access Decision News Media e-newsletters for the food, beverage & nutition industries click here


To continue to receive this newsletter in your inbox, please add
newsletter@outsourcing-pharma.com to your address book

Update preferences | Change your email address | ***

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2006 - Decision News Media S.A.S - All Rights Reserved
La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France
http://www.decisionnewsmedia.com